1. Market Research
  2. > Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review

Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Genus plc (Genus) is a global animal genetic company. The company is involved in the application of quantitative genetics and biotechnology to animal breeding primarily in two sectors, namely, bovine and porcine. The primary activities of the company include supply of dairy and beef cattle semen under ABS trademark; supply of pigs and their semen under PIC trade mark; and other value added and technical support services. The key customers of the company include farmers, breeders, processors, distributors, retailers, and consumers. The company has its operations in North America, Latin America, Europe and Far East. It has its research and development (R&D) laboratories in Madison, Wisconsin. Genus is headquartered in Basingstoke, the UK.

Genus Plc Key Recent Developments

Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth
Sep 07, 2016: Genus Announces Non-Executive Director Retirement
Aug 15, 2016: Genus: Final Jury Decisions in US Litigation
Aug 12, 2016: Genus: Further Decisions in US Litigation
Mar 04, 2016: Genus announces board of director


Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Genus Plc (GNS) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Genus Plc - Key Facts 6
Genus Plc - Key Employees 7
Genus Plc - Key Employee Biographies 8
Genus Plc - Major Products and Services 9
Genus Plc - History 10
Genus Plc - Company Statement 12
Genus Plc - Locations And Subsidiaries 14
Head Office 14
Other Locations and Subsidiaries 14
Section 2 - Company Analysis 17
Genus Plc - Business Description 17
Genus Plc - Corporate Strategy 18
Genus Plc - SWOT Analysis 19
SWOT Analysis - Overview 19
Genus Plc - Strengths 19
Genus Plc - Weaknesses 20
Genus Plc - Opportunities 21
Genus Plc - Threats 22
Genus Plc - Key Competitors 23
Section 3 - Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 - Company's Lifesciences Financial Deals and Alliances 30
Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30
Genus Plc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 31
Genus Plc, Recent Deals Summary 32
Section 5 - Company's Recent Developments 33
Sep 08, 2016: Genus: Preliminary Results for the year ended 30 June 2016 Significant Strategic Progress and Continued Profit Growth 33
Sep 07, 2016: Genus Announces Non-Executive Director Retirement 34
Aug 15, 2016: Genus: Final Jury Decisions in US Litigation 35
Aug 12, 2016: Genus: Further Decisions in US Litigation 36
Mar 04, 2016: Genus announces board of director 37
Section 6 - Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42


List of Tables
Genus Plc, Key Facts 6
Genus Plc, Key Employees 7
Genus Plc, Key Employee Biographies 8
Genus Plc, Major Products and Services 9
Genus Plc, History 10
Genus Plc, Subsidiaries 14
Genus Plc, Key Competitors 23
Genus Plc, Ratios based on current share price 24
Genus Plc, Annual Ratios 25
Genus Plc, Interim Ratios 28
Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30
Genus Plc, Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 31
Genus Plc, Recent Deals Summary 32
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41


List of Figures
Genus Plc, Performance Chart (2012 - 2016) 27
Genus Plc, Ratio Charts 29
Genus Plc, Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 30
Genus Plc, Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 31

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.